Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe.

Ann Oncol

Amsterdam UMC, University of Amsterdam, Amsterdam; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.

Published: November 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.annonc.2022.07.006	DOI Listing

Publication Analysis

molecular profiling

profiling precision

precision medicine

medicine rare

rare gastrointestinal

gastrointestinal cancers

cancers euracan

euracan specta

specta arcagen

arcagen study

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!